When in Rome, NY … don’t do as forbidden in Rome, PA: The US’ Increasingly convoluted regulation of early human development research
How will the fall of Roe v. Wade likely affect human embryo research? The author explains. Continue Reading
Author: dm62
Vaccine equity in Texas: What we got wrong and where we go from here
If we want to learn from the mistakes made in early vaccine rollout, it’s critical that we look back on the details of Texas’ response to the development of the COVID-19 vaccines, how this response impacted the ability of different communities to get immunized, and what changes we can make going forward that would improve outcomes for all during the next public health crisis. Continue Reading
The Nobel science prizes: The good, the bad and the ugly
For all of the good they do to improve public understanding of science, the Nobel Prizes also have major issues. The laureate selection lacks diversity and rewards individuals, promoting competition versus collaboration in science. Continue Reading
Competing bills in Congress warrant a reevaluation of our nation’s priorities
To best advance U.S. scientific and technological innovation, the National Science Foundation reauthorization bill should reconcile key differences between the House’s NSF for the Future Act and Senate’s Endless Frontier Act.
Continue Reading
COVID-19 and the growing gap in access to education
The COVID-19 pandemic has widened the educational gap between students from high- and low-income households. School administrators from the elementary to the college level must address the disparities between these groups to resolve America’s deepening education crisis. Continue Reading
What I learned in 2020: Take time to enjoy the little things
I’ve learned to appreciate small moments of beauty and promise peppered a year filled with doubt and frustration. I hope to take this mindset forward into the future, to admire the little things and make small changes to subtly improve my mood and the world around me. Continue Reading
What I learned in 2020
This year, COVID-19 brought science to the forefront, and we learned how impressive and resilient the U.S. scientific enterprise is. Continue Reading